Table: Cosmos Pharmaceutical -2020/21 parent results
Jul 12 (Reuters)-
Cosmos Pharmaceutical Corp.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
May 31, 2021 May 31, 2020 May 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 726.42 684.40
(+6.1 pct) (+12.0 pct)
Operating 33.12 29.07
(+13.9 pct) (+17.5 pct)
Recurring 35.82 31.54
(+13.5 pct) (+15.7 pct)
Net 27.15 21.42
(+26.7 pct) (+11.8 pct)
EPS 685.52 yen 541.01 yen
Ann Div 70.00 yen 110.00 yen 80.00 yen
-Q2 Div 27.50 yen 50.00 yen 40.00 yen
-Q4 Div 42.50 yen 60.00 yen 40.00 yen
NOTE - Cosmos Pharmaceutical Corp..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T